Similar articles for PMID: 33246975

Year	Number of Results
2002	1
2003	1
2008	2
2009	1
2011	1
2013	1
2014	3
2015	5
2016	13
2017	13
2018	16
2019	19
2020	27
2021	22
2022	9
2023	2
2024	0

1

Preclinical Evaluation of ²¹³Bi- and ²²⁵Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer.

Banerjee SR, Lisok A, Minn I, Josefsson A, Kumar V, Brummet M, Boinapally S, Brayton C, Mease RC, Sgouros G, Hobbs RF, Pomper MG. Banerjee SR, et al. J Nucl Med. 2021 Jul 1;62(7):980-988. doi: 10.2967/jnumed.120.256388. Epub 2020 Nov 27. J Nucl Med. 2021. PMID: 33246975 Free PMC article.

2

Preclinical Evaluation of ^203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer.

Banerjee SR, Minn I, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess AP, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG. Banerjee SR, et al. J Nucl Med. 2020 Jan;61(1):80-88. doi: 10.2967/jnumed.119.229393. Epub 2019 Jun 28. J Nucl Med. 2020. PMID: 31253744 Free PMC article.

3

¹⁷⁷Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG. Banerjee SR, et al. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2545-2557. doi: 10.1007/s00259-019-04434-0. Epub 2019 Aug 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 31399803 Free PMC article.

4

An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy.

Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG. Mease RC, et al. J Nucl Med. 2022 Feb;63(2):259-267. doi: 10.2967/jnumed.121.262098. Epub 2021 Jun 4. J Nucl Med. 2022. PMID: 34088772 Free PMC article.

5

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.

Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG. Kiess AP, et al. J Nucl Med. 2016 Oct;57(10):1569-1575. doi: 10.2967/jnumed.116.174300. Epub 2016 May 26. J Nucl Med. 2016. PMID: 27230930 Free PMC article.

6

Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer.

Shen CJ, Minn I, Hobbs RF, Chen Y, Josefsson A, Brummet M, Banerjee SR, Brayton CF, Mease RC, Pomper MG, Kiess AP. Shen CJ, et al. Theranostics. 2020 Feb 3;10(7):2888-2896. doi: 10.7150/thno.38882. eCollection 2020. Theranostics. 2020. PMID: 32194842 Free PMC article.

7

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

8

Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.

Banerjee SR, Foss CA, Pullambhatla M, Wang Y, Srinivasan S, Hobbs RF, Baidoo KE, Brechbiel MW, Nimmagadda S, Mease RC, Sgouros G, Pomper MG. Banerjee SR, et al. J Nucl Med. 2015 Apr;56(4):628-34. doi: 10.2967/jnumed.114.149062. Epub 2015 Feb 26. J Nucl Med. 2015. PMID: 25722448 Free PMC article.

9

Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using ¹⁹F/¹⁷⁷Lu-rhPSMA-7.3 and ¹⁷⁷Lu-PSMA I&T.

Yusufi N, Wurzer A, Herz M, D'Alessandria C, Feuerecker B, Weber W, Wester HJ, Nekolla S, Eiber M. Yusufi N, et al. J Nucl Med. 2021 Aug 1;62(8):1106-1111. doi: 10.2967/jnumed.120.254516. Epub 2020 Dec 18. J Nucl Med. 2021. PMID: 33443072 Free article.

10

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.

Kratochwil C, Bruchertseifer F, Rathke H, Bronzel M, Apostolidis C, Weichert W, Haberkorn U, Giesel FL, Morgenstern A. Kratochwil C, et al. J Nucl Med. 2017 Oct;58(10):1624-1631. doi: 10.2967/jnumed.117.191395. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408529 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year